In the UK, there was a case where TGN1412, an immunotherapy under development, triggered a cytokine storm within hours of ...
A biomedical researcher combining advanced mouse models with human-based and computational approaches explains why we can’t ...
The U.S. Food and Drug Administration’s recently published Roadmap to Reducing Animal Testing in Preclinical Safety Studies may have caused a stir across the pharmaceutical and biotech industries, but ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...
A new human liver organoid microarray developed by Cincinnati Children’s and Roche recreates immune-driven liver injury in the lab. Built from patient-derived stem cells and immune cells, it ...
A human model of immune-driven liver injury Some drugs that pass early safety testing can still cause idiosyncratic drug-induced liver injury (iDILI)—a rare immune reaction that can lead to severe ...
AlphaFold, the revolutionary, Nobel-prizewinning tool for predicting protein structures, has a problem: it’s running low on data. The latest version of the artificial intelligence (AI) model, ...
The nonprofit said its new tool, using data from urine tests, has already picked up a spike of carfentanil, a potent and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback